RT Journal Article
SR Electronic
T1 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A972
OP A972
DO 10.1136/jitc-2023-SITC2023.0873
VO 11
IS Suppl 1
A1 Chen, Celia
A1 Liu, Jin
A1 Wu, Jianyu
A1 Cheng, Xin
A1 Qin, Luoheng
A1 Bavadekar, Supriya
A1 Zhang, Man
A1 Rao, Sujata
A1 Ren, Feng
A1 Zhavoronkov, Alex
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A972.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.